bonjesta tabletas de liberación prolongada
duchesnay inc canada - doxilamina succinato 20.0 mg clorhidrato de piridoxina 20.0 mg - tabletas - cada tableta de liberacion prolongada contiene: doxilamina succinato ---------- 20.0 mg clorhidrato de piridoxina-------20.0 mg
reduce fat fast capsula
calanit s.a.c. - capsula - por capsula; camellia sinensis l. (te verde) 250.000000 mg;
reduce fat new & improved capsula
calanit s.a.c. - capsula
reduce fat fast cápsulas
natural premier suplements corp. - cápsulas
reduce fat fast cápsulas
natural premier suplements corp. - te de java, te verde camellia sinensis - cápsulas
ducha intima medicada
laboratorios rider ltda. - sin formulas
efexor xr cápsulas con gránulos recubiertos de liberación prolongada 225 mg
laboratorios wyeth llc. - venlafaxina - sin formulas
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - neoplasmas estomacales - agentes antineoplásicos - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
venlafaxina retard teva 225 mg capsulas duras de liberacion prolongada efg, 30 capsu
venlafaxina retard teva 225 mg capsulas duras de liberacion prolongada efg, 30 capsu